5:24 PM
 | 
Jan 08, 2013
 |  BC Extra  |  Company News

GE imaging agent accepted for review in U.S., EU

GE Healthcare said FDA and EMA accepted for review regulatory applications for PET imaging agent [18F]-flutemetamol for the visual detection of beta amyloid in the brains...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >